T. Rowe Price Associates
GUTS icon

T. Rowe Price Associates’s Fractyl Health GUTS Stock Holding History

T. Rowe Price Associates’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,313
Closed -$14K – 3162
2025
Q1 		$14K Hold
11,313
– – ﹤0.01% 3020
2024
Q4 		$24K Sell
11,313
-68,500
-86% -$159K ﹤0.01% 2987
2024
Q3 		$203K Buy
+79,813
New +$260K ﹤0.01% 2645

Other funds holding GUTS

GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

T. Rowe Price Associates's GUTS Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Fractyl Health (GUTS) in Q2 2025, closing a stake of 11,313 shares — an estimated $14K sold.

T. Rowe Price Associates first reported a position in GUTS in Q3 2024 and held it in 3 quarters. The position peaked at $203K in Q3 2024. 62 funds tracked by Wall St. Rank hold GUTS as of Q2 2025.

  • T. Rowe Price Associates reported no remaining Fractyl Health position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 11,313 Fractyl Health shares in Q2 2025, an estimated $14K.
  • T. Rowe Price Associates first reported a position in Fractyl Health in Q3 2024 and held it in 3 quarters.
  • T. Rowe Price Associates's Fractyl Health position peaked at $203K in Q3 2024.
  • 62 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.